Multiple ascending doses of recombinant human lecithin-cholesterol acyltransferase in patients with atherosclerosis: phase 2a primary results

被引：0
|
作者：
Bonaca, M. [1 ]
George, R. T. [2 ]
Morrow, D. A. [1 ]
Abuhsira, L. [2 ]
She, D. [2 ]
Park, J. G. [1 ]
Hirshberg, B. [2 ]
Sabatine, M. [1 ]
机构：
[1] Brigham & Womens Hosp, Med, Cardiol, Vasc Med, 75 Francis St, Boston, MA 02115 USA
[2] MedImmune, Gaithersburg, MD USA
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
354
引用
收藏
页码：49 / 50
页数：2
相关论文
共 50 条
  • [41] Results of a phase 1B study of recombinant human APO2L/trail with rituximab in patients with relapsed, low-grade NHL
    Fanale, M.
    Burris, H.
    Yee, L.
    Lucas, J.
    Dimick, K.
    Goldwasser, M.
    Novotny, W.
    Bray, G.
    ANNALS OF ONCOLOGY, 2008, 19 : 161 - 161
  • [42] A Phase 2a Study of MEDI5872 (AMG557), a Fully Human Anti-ICOS Ligand Monoclonal Antibody in Patients with Primary Sjogren's Syndrome
    Mariette, Xavier
    Bombardieri, Michele
    Alevizos, Ilias
    Moate, Rachel
    Sullivan, Barbara
    Noaiseh, Ghaith
    Kvarnstrom, Marika
    Rees, William
    Wang, Liangwei
    Illei, Gabor
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] Efavaleukin Alfa, a Novel IL-2 Mutein, Selectively Expands Regulatory T Cells in Patients with SLE: Interim Results of a Phase 1b Multiple Ascending Dose Study
    Tchao, Nadia
    Amouzadeh, Hamid
    Sarkar, Nandita
    Chow, Vincent
    Hu, Xuguang
    Kroenke, Mark
    Wang, Hui
    Zhang, Rong
    Gorski, Kevin
    Furie, Richard
    Kivitz, Alan
    Cohen, Stanley
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3613 - 3615
  • [44] EFAVALEUKIN ALFA, A NOVEL IL-2 MUTEIN, SELECTIVELY EXPANDS REGULATORY T CELLS IN PATIENTS WITH SLE: FINAL RESULTS OF A PHASE 1B MULTIPLE ASCENDING DOSE STUDY
    Tchao, N.
    Sarkar, N.
    Hu, X.
    Zhang, R.
    Milmont, C.
    Jin, Y. Shi
    Chow, V.
    Kroenke, M.
    Gorski, K.
    Furie, R.
    Kivitz, A.
    Cohen, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1343 - 1344
  • [45] Primary analysis of phase 2 results for cemiplimab, a human monoclonal anti-PD-1, in patients with metastatic cutaneous squamous cell carcinoma (mCSCC)
    Rischin, Danny
    Migden, Michael Robert
    Chang, Anne
    Chung, Christine H.
    Dunn, Lara
    Guminski, Alexander
    Hauschild, Axel
    Hernandez-Aya, Leonel
    Hughes, Brett Gordon Maxwell
    Lewis, Karl D.
    Lim, Annette May Ling
    Modi, Badri
    Schadendorf, Dirk
    Schmults, Chrysalyne
    Booth, Jocelyn
    Li, Siyu
    Mohan, Kosalai Kal
    Stankevich, Elizabeth
    Lowy, Israel
    Fury, Matthew G.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [46] Efficacy of Low-Dose Interferon α2a 18 Versus 60 Months of Treatment in Patients With Primary Melanoma of ≥ 1.5 mm Tumor Thickness: Results of a Randomized Phase III DeCOG Trial
    Hauschild, Axel
    Weichenthal, Michael
    Rass, Knuth
    Linse, Ruthild
    Berking, Carola
    Boettjer, Joerg
    Vogt, Thomas
    Spieth, Konstanze
    Eigentler, Thomas
    Brockmeyer, Norbert H.
    Stein, Annette
    Naeher, Helmut
    Schadendorf, Dirk
    Mohr, Peter
    Kaatz, Martin
    Tronnier, Michael
    Hein, Ruediger
    Schuler, Gerold
    Egberts, Friederike
    Garbe, Claus
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (05) : 841 - 846
  • [47] Patient Preferences for Recombinant Human Hyaluronidase (rHuPH20)-Facilitated Subcutaneous (SC) Infusion of Immunoglobulin G (IGHy) in Adult Patients with Primary Immunodeficiencies (PI): Phase 3 Study Results
    Ito, Diane
    Ye, Xiaolan
    Xiong, Yan
    Li-McLeod, Josephine
    Schiff, Richard
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (03) : 376 - 376
  • [48] KSI-501: a bispecific fusion protein antibody inhibiting both interleukin-6 and vascular endothelial growth factor. First-in human-trial results of multiple ascending doses in patients with diabetic macular edema
    Wykoff, Charles Clifton
    Janer, Daniel
    Zawadzki, Rezi
    Perlroth, D. Victor
    Velazquez-Martin, Pablo
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [49] Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an OpenLabel, Multicenter, Phase 2 Study
    Xue, Feng
    Chen, Weizhi
    Guo, Shuxia
    Hua, Haiying
    Cao, Yu
    Feng, Xianqi
    Yang, Renchi
    BLOOD, 2023, 142
  • [50] RESULTS AFTER 12 WEEKS TREATMENT OF MULTIPLE DOSES OF GSK3389404 IN CHRONIC HEPATITIS B (CHB) SUBJECTS ON STABLE NUCLEOS(T)IDE THERAPY IN A PHASE 2a DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Yuen, Man-Fung
    Heo, Jeong
    Kumada, Hiromitsu
    Suzuki, Fumitaka
    Suzuki, Yoshiyuki
    Xie, Qing
    Jia, Jidong
    Karino, Yoshiyasu
    Hou, Jinlin
    Chayama, Kazuaki
    Imamura, Michio
    Lao-Tan, Judy Y.
    Lim, Seng Gee
    Tanaka, Yasuhito
    Xie, Wen
    Yoon, Jung-Hwan
    Duan, Zhongping
    Kurosaki, Masayuki
    Park, Sung-Jae
    Labio, Eternity
    Kumar, Rajneesh
    Kweon, Young-Oh
    Yim, Hyung Joon
    Cremer, Jennifer
    Elston, Robert
    Chen, Shuguang
    Davies, Matt
    Baptiste-Brown, Sharon
    Han, Kelong
    Campbell, Fiona M.
    Paff, Melanie
    Theodore, Dickens
    HEPATOLOGY, 2019, 70 : 433A - 434A
12345